Lee Myunghwan, Kwon Taegeon, Kim Sujin, Kim Saeyoung, Park Kibum, Jeon Younghoon
Department of Oral and Maxillofacial surgery, School of Dentistry Department of Anesthesiology and Pain Medicine, Kyungpook National University Hospital Department of Anesthesiology and Pain Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.
Medicine (Baltimore). 2017 Mar;96(10):e6288. doi: 10.1097/MD.0000000000006288.
Propofol is associated with pain during injection, which is stressful to patients. The present study was designed to investigate the analgesic effect of pretreatment with remifentanil and esmolol in minimizing propofol injection pain, compared with placebo.
In a randomized, double-blind, prospective trial, 120 patients, scheduled for elective dental surgery under general anesthesia, were randomized to 1 of the 4 treatment arms (n = 30 each) receiving normal saline, remifentanil 0.35 μg/kg, esmolol 0.5 mg/kg, and 1 mg/kg before administration of propofol. During injection of 1% propofol 0.5 mg/kg, pain was evaluated by a 4-point score (0 = none, 1 = mild, 2 = moderate, 3 = severe). Any adverse effects such as hypotension and bradycardia were recorded during the perioperative periods.
In all, 120 patients completed this study. There were no significant differences in terms of demographic data. The incidence of pain on injection of propofol was 11 (36.7%) with remifentanil 0.35 μg/kg, 12 (40%) with esmolol 0.5 mg/kg, and 11 (36.7%) with esmolol 1 mg/kg, compared with 25 (83.3%) with normal saline (respectively, P < 0.05). There were no significant differences in the incidence of pain between groups with remifentanil 0.35 μg/kg, and esmolol 0.5 mg/kg and 1 mg/kg. There were no emergence reactions such as hypotension and bradycardia in all groups.
Pretreatment with esmolol 0.5 mg/kg and 1 mg/kg and remifentanil 0.35 μg/kg equally decreased pain during propofol injection.
丙泊酚注射时会引起疼痛,这给患者带来压力。本研究旨在探讨瑞芬太尼和艾司洛尔预处理在减轻丙泊酚注射疼痛方面的镇痛效果,并与安慰剂进行比较。
在一项随机、双盲、前瞻性试验中,120例计划在全身麻醉下进行择期牙科手术的患者被随机分为4个治疗组之一(每组n = 30),在注射丙泊酚前分别接受生理盐水、0.35μg/kg瑞芬太尼、0.5mg/kg艾司洛尔和1mg/kg艾司洛尔。在注射1%丙泊酚0.5mg/kg期间,通过4分制评分(0 = 无,1 = 轻度,2 = 中度,3 = 重度)评估疼痛程度。在围手术期记录任何不良反应,如低血压和心动过缓。
总共120例患者完成了本研究。在人口统计学数据方面无显著差异。注射丙泊酚时的疼痛发生率,使用0.35μg/kg瑞芬太尼组为11例(36.7%),0.5mg/kg艾司洛尔组为12例(40%),1mg/kg艾司洛尔组为11例(36.7%),而生理盐水组为25例(83.3%)(P均<0.05)。0.35μg/kg瑞芬太尼组与0.5mg/kg和1mg/kg艾司洛尔组之间的疼痛发生率无显著差异。所有组均未出现低血压和心动过缓等苏醒反应。
0.5mg/kg和1mg/kg艾司洛尔以及0.35μg/kg瑞芬太尼预处理在丙泊酚注射期间同等程度地减轻了疼痛。